Indication
High-grade glioma
2 clinical trials
2 products
Clinical trial
A Phase Ib/II Study on AsiDNA in Association With Re-irradiation in Children, Adolescents and Young Adults With High-grade GliomaStatus: Terminated, Estimated PCD: 2023-09-20
Product
AsiDNAClinical trial
A Phase 1, Open-Label Window-of-Opportunity Study to Assess the Pharmacokinetics, Pharmacodynamics and Central Nervous System (CNS) Penetration of Xevinapant in Preoperative Subjects With Recurrent High-Grade Glioma (rHGG)Status: Not yet recruiting, Estimated PCD: 2027-06-01
Product
Xevinapant